Search | IOVS | ARVO Journals

Showing 1 – 20 of 29

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Changes in Signs and Symptoms of Dry Eye Disease after using 0.1% or 0.05% Emulsions of Cyclosporine A Eye Drops

Jonatan Olafsson; Øygunn Aass Utheim; Xiangjun Chen; Snorri Olafsson; Sten Raeder; Darlene A Dartt; Behzod Tashbayev; Tor Paaske Utheim

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):912.

ARVO Annual Meeting Abstract July 2018

Prevalence of Meibomian Gland Dysfunction in a Norwegian Working-Age Population Seeking Specialist Eye Care for Dry Eye Symptoms

Reza A Badian; Tor Paaske Utheim; Sten Raeder; Øygunn Aass Utheim; Xiangjun Chen; Behzod Tashbayev; Bente Monica Aakre; Ann Elisabeth Ystenas; Vibeke Sundling

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):928.

ARVO Annual Meeting Abstract June 2017

Improvement of Key Clinical Parameters of Dry Eye Disease after 12 Months Treatment with Cyclosporine 0.05% Eye Drops

Tor Paaske Utheim; Xianjun Chen; Sten Raeder; Øygunn Utheim; Aleksandar Stojanovic; Darlene A Dartt; Behzod Tashbayev

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2660.

ARVO Annual Meeting Abstract September 2016

Clinical findings of Dry Eye Disease in a large Norwegian cohort based on osmolarity measurements

Sjur Reppe; Xiangjun Chen; Sten Ræder; Tor Paaske Utheim; Øygunn Aass Utheim; Aleksandar Stojanovic; Neil S Lagali; Darlene A Dartt; Behzod Tashbayev

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2859.

ARVO Annual Meeting Abstract September 2016

Treatment Effects in a Norwegian Cohort of Dry Eye Patients with Meibomian Gland Dysfunction Following Treatment According to Guidelines of The International Workshop on Meibomian Gland Dysfunction (2011): Three and Six Months Follow-up

Catherine Jackson; Behzod Tashbayev; Sten Ræder; Tor Paaske Utheim; Øygunn Aass Utheim; Aleksandar Stojanovic; Neil S Lagali; Darlene A Dartt; Xiangjun Chen

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5665.

ARVO Annual Meeting Abstract September 2016

Morphological Evaluation of Meibomian Glands in Patients with Dry Eye Disease

Muhammed Yasin Adil; Jiaxin Xiao; Jonatan Olafsson; Tor Paaske Utheim; Sten Ræder; Øygunn Aass Utheim; Neil S Lagali; Darlene A Dartt; Xiangjun Chen

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5676.

ARVO Annual Meeting Abstract September 2016

Subjective and Objective Assessment of Meibography Images

Jiaxin Xiao; Muhammed Yasin Adil; Jonatan Olafsson; Tor Paaske Utheim; Sten Ræder; Øygunn Aass Utheim; Neil S Lagali; Darlene A Dartt; Xiangjun Chen

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5677.

ARVO Annual Meeting Abstract April 2014

Age-associated Differences in Severity of Ocular Signs in Dry Eye Disease Patients

Reza A. Badian; Sten Ræder; Tor Paaske Utheim; Øygunn A Utheim; Xiangjun Chen; Aleksandar Stojanovic; Darlene Dartt; Jon Roger Eidet

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1984.

ARVO Annual Meeting Abstract April 2014

Dry Eye Disease Patients with Xerostomia Report Higher Symptomatic Burden

Ida Grunnan Fostad; Jon Roger Eidet; Sten Ræder; Neil S Lagali; Edward B Messelt; Janicke L Jensen; Hilde K Galtung; Darlene Dartt; Tor Paaske Utheim

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1995.

ARVO Annual Meeting Abstract April 2014

Improved Staining, Tear Film Breakup Time, and Dry Eye Severity Level Following a Six-Month Treatment of a Cohort of Dry Eye Patients in Norway

Jon Roger Eidet; Tor Paaske Utheim; Øygunn A Utheim; Xiangjun Chen; Aleksandar Stojanovic; Sten Ræder

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6302.

ARVO Annual Meeting Abstract June 2013

Symptoms and Findings in a Norwegian Cohort of Patients with Meibomian Gland Dysfunction

Ola Rygh; Jon Roger Eidet; Xiangjun Chen; Tor Utheim; Andreas Thyholdt; Oeygunn Aass Utheim; Filip Stojanovic; Aleksandar Stojanovic; Sten Raeder

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):6009.

Cornea May 2012

Effect of Biopsy Location and Size on Proliferative Capacity of Ex Vivo Expanded Conjunctival Tissue

PDF

Jon R. Eidet; Ida G. Fostad; Marie A. Shatos; Tor P. Utheim; Øygunn A. Utheim; Sten Raeder; Darlene A. Dartt
TAGS: biopsy, body tissue, conjunctiva, phenotype
Invest. Ophthalmol. Vis. Sci.. 2012; 53(6):2897-2903. https://doi.org/10.1167/iovs.11-8269

ARVO Annual Meeting Abstract April 2011

The MicroRNA And MessengerRNA Gene Expression Signature Of Human Primary Pterygium

David H. Engelsvold; Harald F. Ulltveit-Moe; Ole K. Olstad; Tor P. Utheim; Jon R. Eidet; Øygunn A. Utheim; Vegard Forsaa; Marketa Jenssen; Torstein Lyberg; Sten Raeder

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3365.

ARVO Annual Meeting Abstract April 2011

Strict Face Down Positioning Compared With No Face Down Positioning In The Repair Of Macular Hole

Vegard A. Forsaa; Laila T. Hashemi; Sten Raeder; Joergen Krohn

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4492.

ARVO Annual Meeting Abstract April 2011

Comparison of Storage of Cultured Human Limbal Epithelial Cells in HEPES-MEM, Optisol-GS and PAA Quantum 286 for 4 days at 23°C

Tor P. Utheim; Øygunn A. Utheim; Jon R. Eidet; Maria de la Paz; Sten Raeder; Borghild B. Roald; Torstein Lyberg

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5124.

ARVO Annual Meeting Abstract April 2011

Xenobiotic- and Serum-Free Culture Protocol for Autologous Cultivated Oral Mucosal Epithelial Cells on Therapeutic Contact Lenses

Harald F. Ulltveit-Moe; Jon R. Eidet; Benny Björkblom; Simon G. Møller; Tor P. Utheim; David H. Engelsvold; Oeygunn A. Utheim; Torstein Lyberg; Sten Raeder

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5157.

ARVO Annual Meeting Abstract April 2010

When Your Anti-VEGF Agent Fails, Will the Other One Succeed?

L. T. Hashemi; S. Raeder; A. Takserman; H. Ulltveit-Moe; V. A. Forsaa

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):83.

ARVO Annual Meeting Abstract April 2010

The Effect of VEGF Inhibitors Administrated on "Inject and Extend" Dosing Strategy in Patients Treated for Unilateral CNV and New-Onset CNV in the Fellow Eye

A. Takserman; H. F. Ulltveit-Moe; P. Bjerga; L. T. Hashemi; S. Raeder; V. A. Forsaa

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):86.

ARVO Annual Meeting Abstract April 2010

Effect of Biopsy Location and Size on Phenotype and Proliferative Ability of Cultured Rat Conjunctival Tissue

J. Eidet; I. G. Fostad; M. Shatos; T. P. Utheim; O. A. Utheim; S. Raeder; D. A. Dartt

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):1912.

ARVO Annual Meeting Abstract April 2010

A Comparison of Treatment With Intravitreal Ranibizumab and Bevacizumab in Patients With Central Retinal Vein Occlusion Using a "Treat and Extend" Dosing Regimen

H. F. Ulltveit-Moe; A. Takserman; P. Bjerga; L. T. Hashemi; S. Raeder; V. A. Forsaa

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):4719.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Changes in Signs and Symptoms of Dry Eye Disease after using 0.1% or 0.05% Emulsions of Cyclosporine A Eye Drops

Prevalence of Meibomian Gland Dysfunction in a Norwegian Working-Age Population Seeking Specialist Eye Care for Dry Eye Symptoms

Improvement of Key Clinical Parameters of Dry Eye Disease after 12 Months Treatment with Cyclosporine 0.05% Eye Drops

Clinical findings of Dry Eye Disease in a large Norwegian cohort based on osmolarity measurements

Treatment Effects in a Norwegian Cohort of Dry Eye Patients with Meibomian Gland Dysfunction Following Treatment According to Guidelines of The International Workshop on Meibomian Gland Dysfunction (2011): Three and Six Months Follow-up

Morphological Evaluation of Meibomian Glands in Patients with Dry Eye Disease

Subjective and Objective Assessment of Meibography Images

Age-associated Differences in Severity of Ocular Signs in Dry Eye Disease Patients

Dry Eye Disease Patients with Xerostomia Report Higher Symptomatic Burden

Improved Staining, Tear Film Breakup Time, and Dry Eye Severity Level Following a Six-Month Treatment of a Cohort of Dry Eye Patients in Norway

Symptoms and Findings in a Norwegian Cohort of Patients with Meibomian Gland Dysfunction

Effect of Biopsy Location and Size on Proliferative Capacity of Ex Vivo Expanded Conjunctival Tissue

The MicroRNA And MessengerRNA Gene Expression Signature Of Human Primary Pterygium

Strict Face Down Positioning Compared With No Face Down Positioning In The Repair Of Macular Hole

Comparison of Storage of Cultured Human Limbal Epithelial Cells in HEPES-MEM, Optisol-GS and PAA Quantum 286 for 4 days at 23°C

Xenobiotic- and Serum-Free Culture Protocol for Autologous Cultivated Oral Mucosal Epithelial Cells on Therapeutic Contact Lenses

When Your Anti-VEGF Agent Fails, Will the Other One Succeed?

The Effect of VEGF Inhibitors Administrated on "Inject and Extend" Dosing Strategy in Patients Treated for Unilateral CNV and New-Onset CNV in the Fellow Eye

Effect of Biopsy Location and Size on Phenotype and Proliferative Ability of Cultured Rat Conjunctival Tissue

A Comparison of Treatment With Intravitreal Ranibizumab and Bevacizumab in Patients With Central Retinal Vein Occlusion Using a "Treat and Extend" Dosing Regimen

To View More...

You must be signed into an individual account to use this feature.